62 related articles for article (PubMed ID: 2871012)
21. Management strategies for the treatment of schizophrenia.
Kane JM
J Clin Psychiatry; 1999; 60 Suppl 12():13-7. PubMed ID: 10372604
[TBL] [Abstract][Full Text] [Related]
22. Observations on the use of long-acting depot neuroleptic injections in the maintenance therapy of schizophrenia.
Johnson DA
J Clin Psychiatry; 1984 May; 45(5 Pt 2):13-21. PubMed ID: 6143743
[TBL] [Abstract][Full Text] [Related]
23. Review of treatments that can ameliorate nonadherence in patients with schizophrenia.
Kane JM
J Clin Psychiatry; 2006; 67 Suppl 5():9-14. PubMed ID: 16822091
[TBL] [Abstract][Full Text] [Related]
24. [Neuroleptic low-dose long-term strategy and intermittent therapy strategy in chronic schizophrenia--a critical review].
Hofmann P; Melisch B; Zapotoczky HG; Kulhanek F
Fortschr Neurol Psychiatr; 1993 Jun; 61(6):195-200. PubMed ID: 8101177
[TBL] [Abstract][Full Text] [Related]
25. Prevention of relapse in chronic schizophrenic patients.
Hogarty GE
J Clin Psychiatry; 1993 Mar; 54 Suppl():18-23. PubMed ID: 8097193
[TBL] [Abstract][Full Text] [Related]
26. [New chemotherapy approaches to psychoses].
Olié JP; Baylé FJ
Encephale; 1997 Apr; 23 Spec No 2():2-9. PubMed ID: 9273302
[TBL] [Abstract][Full Text] [Related]
27. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
Woods SW; Gueorguieva RV; Baker CB; Makuch RW
Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728
[TBL] [Abstract][Full Text] [Related]
28. Review of the evidence for the long-term efficacy of atypical antipsychotic agents in the treatment of patients with schizophrenia and related psychoses.
Turner MS; Stewart DW
J Psychopharmacol; 2006 Nov; 20(6 Suppl):20-37. PubMed ID: 17046985
[TBL] [Abstract][Full Text] [Related]
29. First-episode schizophrenia. Early intervention and medication discontinuation in the context of course and treatment.
Wyatt RJ; Damiani LM; Henter ID
Br J Psychiatry Suppl; 1998; 172(33):77-83. PubMed ID: 9764131
[TBL] [Abstract][Full Text] [Related]
30. Oral ziprasidone in the treatment of schizophrenia: a review of short-term trials.
Kane JM
J Clin Psychiatry; 2003; 64 Suppl 19():19-25. PubMed ID: 14728086
[TBL] [Abstract][Full Text] [Related]
31. Long-acting injectable antipsychotics in the treatment of schizophrenia: their role in relapse prevention.
Agid O; Foussias G; Remington G
Expert Opin Pharmacother; 2010 Oct; 11(14):2301-17. PubMed ID: 20586707
[TBL] [Abstract][Full Text] [Related]
32. The efficacy of antipsychotic drugs and family therapies in the maintenance treatment of schizophrenia.
Schooler NR
J Clin Psychopharmacol; 1986 Feb; 6(1 Suppl):11S-19S. PubMed ID: 2870086
[TBL] [Abstract][Full Text] [Related]
33. [Discontinuation of neuroleptics in chronic schizophrenics. I. Summary of the literature].
Woggon B
Int Pharmacopsychiatry; 1979; 14(1):34-56. PubMed ID: 39040
[TBL] [Abstract][Full Text] [Related]
34. The choice of neuroleptics in the treatment of schizophrenia: a critical review.
Tansella M; Balestrieri A
Arzneimittelforschung; 1976; 26(5):943-5. PubMed ID: 9102
[TBL] [Abstract][Full Text] [Related]
35. [Therapeutic goal and pharmacotherapy according to clinical stages of schizophrenia].
Furuhashi K; Iwata N
Nihon Rinsho; 2013 Apr; 71(4):635-40. PubMed ID: 23678592
[TBL] [Abstract][Full Text] [Related]
36. Intermittent medication--an alternative?
Gaebel W
Acta Psychiatr Scand Suppl; 1994; 382():33-8. PubMed ID: 7916527
[TBL] [Abstract][Full Text] [Related]
37. Good medical practice in antipsychotic pharmacotherapy.
Peuskens J
Int Clin Psychopharmacol; 1998 Mar; 13 Suppl 3():S35-41. PubMed ID: 9690969
[TBL] [Abstract][Full Text] [Related]
38. Neuroleptic dosing and neuroleptic plasma levels in schizophrenia: determining the optimal regimen.
Shriqui CL
Can J Psychiatry; 1995 Sep; 40(7 Suppl 2):S38-48. PubMed ID: 8564916
[TBL] [Abstract][Full Text] [Related]
39. Maintenance treatment of schizophrenia: a review of dose reduction and family treatment strategies.
Schooler NR; Keith SJ; Severe JB; Matthews SM
Psychiatr Q; 1995; 66(4):279-92. PubMed ID: 8584586
[TBL] [Abstract][Full Text] [Related]
40. Determinants of medication compliance in schizophrenia: empirical and clinical findings.
Fenton WS; Blyler CR; Heinssen RK
Schizophr Bull; 1997; 23(4):637-51. PubMed ID: 9366000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
